US Centers for Disease Control and Prevention (CDC) suspends testing for multiple infectious diseases
Change
The CDC suspended more than two dozen diagnostic tests, including assays for rabies, poxviruses, Epstein-Barr virus and varicella zoster virus, citing workforce reductions, and said it can assist state and local partners in coordinating testing through alternative laboratories.
Why it matters
State and local public-health laboratories that rely on CDC laboratory support can no longer send samples for the paused assays and must find alternate testing providers or delay diagnoses. Laboratories without commercial capacity will face constrained access to specialised confirmation testing and must change sample-routing procedures to maintain surveillance.
Implications
- — Directors of state and local public-health laboratories must immediately secure contracts or transfer agreements with commercial or other public laboratories for the paused assays, or diagnostic confirmations will be delayed.
- — State and local health departments' epidemiology and surveillance teams must revise testing workflows and reporting protocols to route samples to alternate laboratories, or surveillance and case counting will lapse.
Unlock the decision layer.
Know what's at risk and what to do next.
- Implications: What this forces you to change — operations, exposure, or compliance.
- Who is affected: Which roles, contracts, and obligations are exposed.
- What to watch: Binding deadlines and enforcement dates.
- Real-time alerts: Delivered the moment a binding change is published.
- Ask AI: Ask what this means for your specific role.
No credit card · 14-day trial · Active in seconds
Unlock the decision layer